title: Possible Rivaroxaban Failure during the Postpartum Period: An Alternative Viewpoint.
authors.affiliation: Sunnybrook Health Sciences Centre, Thromboembolism and Anticoagulation Management Team, Toronto, Ontario, Canada.|University of Toronto, Toronto, Ontario, Canada.
authors.forename: Alison M
authors.initials: AM
authors.lastname: Bond
authors.affiliation: Sunnybrook Health Sciences Centre, Thromboembolism and Anticoagulation Management Team, Toronto, Ontario, Canada.|University of Toronto, Toronto, Ontario, Canada.
authors.forename: Bill
authors.initials: B
authors.lastname: Bartle
authors.affiliation: Bassett Medical Center, Cooperstown, New York, USA.
authors.forename: Kelly M
authors.initials: KM
authors.lastname: Rudd
authors.affiliation: Bassett Medical Center, Cooperstown, New York, USA.
authors.forename: Amanda R
authors.initials: AR
authors.lastname: McFee Winans
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D065427:Factor Xa Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009025:Morpholines / Q000627:therapeutic use; D049590:Postpartum Period; D000069552:Rivaroxaban; D013876:Thiophenes / Q000627:therapeutic use; D054556:Venous Thromboembolism / Q000188:drug therapy*
chemical_list: D000925:Anticoagulants; D065427:Factor Xa Inhibitors; D009025:Morpholines; D013876:Thiophenes; D000069552:Rivaroxaban
keywords: Failure; Rivaroxaban; Venous Thromboembolism